stella
beta
Clinical Effectiveness and Safety of Trastuzumab Deruxtecan (T-DXd) in Chinese Patients With HER2m NSCLC (RERUN) — Stella
Recruiting
Back to Non-small Cell Lung Cancer trials
Trial locations
(23 sites)
China
Cancer Hospital Chinese Academy of Medical Sciences, Beijing
Peking University International Hospital, Beijing
Beijing Cancer Hospital, Beijing
Hunan Second People's Hospital, Changsha
Fujian Cancer Hospital, Fuzhou
Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou
The First Affiliated Hospital of Sun Yat-sen University, Guangzhou
Zhejiang Cancer Hospital, Hangzhou
Anhui Provincial Cancer Hospital, Hefei
First Affiliated Hospital of Shandong First Medical University, Jinan
Cancer Hospital of Shandong First Medical University, Jinan
The First Affiliated Hospital of Jinzhou Medical University, Jinzhou
The First Affiliated Hospital of Nanchang University, Nanchang
Guangxi Medical University Cancer Hospital, Nanning
Ruijin Hospital, Shanghai Jiaotong University School Of Medicine, Shanghai
Zhongshan Hospital Fudan University, Shanghai
The First Hospital of China Medical University, Shenyang
Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center, Shenzhen
The Fourth Hospital of Hebei Medical University, Shijiazhuang
Shangxi Provincial Cancer Hospital, Taiyuan
The First Affiliated Hospital of Xiamen University, Xiamen
Henan Cancer Hospital, Zhengzhou
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
View full record on ClinicalTrials.gov